RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...

A multi-disciplinary research team at the Wyss Institute at Harvard University, Dana-Farber Cancer Institute, and ...

Next generation influenza vaccines that provide broader and longer-lasting protection than existing seasonal vaccines, could ...

Read more about Future pandemics may be fought faster with mRNA and advanced vaccine platforms on Devdiscourse ...

FDA advisers recommend fall flu shot changes to include the new subclade K H3N2 variant for the 2026-27 season, improving vaccine relevance.

Judge Murphy held that wholesale removal of 17 ACIP experts and installation of largely non-expert replacements failed FACA “fair balance” and committee charter expertise requirements. The injunction ...

Analysis by WHO estimates that 6.2 million lives could be saved if next-generation vaccines are used through to 2050.

Global health officials mandate a new flu vaccine to combat a late-emerging, severe H3N2 variant, as current shots proved 37% ...

Wyss Institute's DoriVac combined vaccine and adjuvant technology uses nanoscale precision enabled by DNA origami to induce broad immunity against ...